Phage infection of bacterial biofilm

This project aims to characterize the dynamics of Herelleviridae phage phi812 in Staphylococcus aureus biofilms to enhance phage therapy effectiveness against antibiotic-resistant infections.

Subsidie
€ 1.992.976
2023

Projectdetails

Introduction

In 2017, the World Health Organization declared Staphylococcus aureus to be an antibiotic-resistant pathogen for which new therapeutics are urgently needed. Upon infection, S. aureus forms biofilms that can only be treated by the long-term application of several antibiotics in high doses or the surgical removal of the infected tissues.

Alternative Approaches

An alternative approach, phage therapy, has not been approved for clinical use because the effects of phage infection on a biofilm are not sufficiently characterized. We propose to study the dynamics of the propagation of Herelleviridae phage phi812 in a S. aureus biofilm and the molecular details of phi812 replication in a cell.

Methodology

We integrated a microfluidic system into a light-sheet microscope to enable continuous multi-day observation of the phage infection of a biofilm. Our research will focus on the following aspects:

  1. Determining how sub-populations of metabolically dormant or phage-resistant cells in a biofilm provide herd immunity against phi812 infection.
  2. Fixing biofilm segments for subsequent correlative imaging by serial block-face scanning electron microscopy to identify the interactions of phages with bacterial cells.
  3. Using focused ion beam milling together with cryo-electron microscopy and tomography to determine high-resolution structures of previously uncharacterized phi812 replication and assembly intermediates in S. aureus cells.

Biological Significance

We will study the function of bacterial membranes and macromolecular complexes in the initiation and completion of phage genome delivery, the assembly of phage portal complexes and heads, and the mechanisms of genome packaging and head-tail attachment.

This proposal's biological significance lies in its focus on the as-yet uncharacterized interactions of phages and bacteria under biologically and clinically relevant conditions. Our analyses of phage spread in a biofilm, herd immunity against phage infection, and phage replication in cells may identify approaches for making phage therapy more effective.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.992.976
Totale projectbegroting€ 1.992.976

Tijdlijn

Startdatum1-1-2023
Einddatum31-12-2027
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • Masarykova univerzitapenvoerder

Land(en)

Czechia

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Advancing Phage Therapy through Synergistic Strategies: Phage-Mediated Killing and Competitive Exclusion using Engineered Prophages

PHAGE-PRO aims to revolutionize phage therapy by utilizing engineered prophages and probiotics for rapid pathogen targeting and sustained efficacy, enhancing infection management in livestock and human medicine.

€ 1.500.000
ERC Starting...

Deciphering stringent response proteins and toxin-antitoxin systems in the arms race between bacteria and phages

This project aims to identify phage proteins that target bacterial defense systems to advance phage therapy and improve bioremediation by studying Pseudomonas putida interactions.

€ 1.499.250
ERC Proof of...

Modification of liposomic nano-carriers: a novel strategy for improved drug-delivery and eradication of bacterial biofilms

This project aims to develop and evaluate a novel drug delivery system to effectively treat and eradicate bacterial biofilms, addressing significant health and economic challenges.

€ 150.000
ERC Starting...

Life of Giant Phages

This project aims to isolate and study giant phages from boreal freshwaters to understand their structure, host interactions, and ecological roles, advancing phage biology and microbial ecology.

€ 1.499.808
ERC Starting...

Phage co-infection: a missing link in deciphering phage co-evolutionary dynamics

MULTIPHAGE aims to revolutionize our understanding of phage genome evolution by investigating co-infection dynamics through innovative omics methods and structural phylogeny.

€ 1.499.401

Vergelijkbare projecten uit andere regelingen

EIC Accelerator

in silico bio-evolutio - novel AI paradigm for molecular biology

This project aims to accelerate phage therapy by using an AI platform for in silico simulations to optimize phage selection, reducing experimental time and enhancing personalized treatment effectiveness.

€ 1.692.596
Mkb-innovati...

Behandeling van antibioticaresistente S. aureus en preventie van verdere antibioticaresistentie

Het project onderzoekt de haalbaarheid van een op antilichamen gebaseerd product voor de behandeling van S. aureus-infecties, gericht op genezing en het voorkomen van antibioticaresistentie.

€ 20.000
EIC Accelerator

Fast, easy diagnostics for personalised phage therapy

Vésale Bioscience's Phagogram is an automated diagnostic tool that rapidly identifies effective bacteriophages for personalized phage therapy, reducing testing time from days to hours.

€ 1.800.000
EIC Pathfinder

Advanced nanomaterials to target genomic and Z-DNA for bacterial biofilm eradication

BactEradiX aims to create a novel antimicrobial nanomaterial targeting biofilm Z-DNA to effectively eradicate chronic infections caused by drug-resistant bacteria.

€ 2.996.312
Mkb-innovati...

InnomABs

IPA onderzoekt de haalbaarheid van het ontwikkelen van menselijke eiwitten als alternatief voor antibiotica tegen antimicrobiële resistentie.

€ 14.888